Portage, MI, United States of America

Matthew W Bedore

USPTO Granted Patents = 7 



Average Co-Inventor Count = 6.5

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):

Title: The Innovations of Matthew W Bedore

Introduction

Matthew W Bedore is a notable inventor based in Portage, MI (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating various diseases. With a total of 7 patents to his name, Bedore's work has had a meaningful impact on medical science.

Latest Patents

Among his latest patents is the invention titled "Immunomodulating o-het/aryl azalides." This patent defines immunomodulating compounds and their stereoisomers, along with methods for treating inflammatory and immunological diseases in animals. Another significant patent is focused on "Heterocyclic compounds and their use for treatment of helminthic infections and diseases," which provides new compounds aimed at addressing these health issues.

Career Highlights

Matthew W Bedore has worked with prominent companies in the pharmaceutical industry, including Zoetis Services LLC and Celgene Corporation. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.

Collaborations

Throughout his career, Bedore has collaborated with notable colleagues such as Graham M Kyne and Richard Andrew Ewin. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Matthew W Bedore's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of treatments for various diseases, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…